Rangwala Reshma - Insider Non-Derivative Transactions at Karyopharm Therapeutics Inc. (KPTI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 22, 2024, Rangwala Reshma's relationship to Karyopharm Therapeutics Inc. (KPTI) is Officer (EVP & Chief Medical Officer), and currently has 342,931 shares of Common Stock, and 349,720 shares of Common.
The the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KPTI insiders.
Data Source: SEC.
Rangwala Reshma - Insider Non-Derivative Transactions of KPTI Common Stock
Rangwala Reshma - Insider Non-Derivative Transactions of KPTI Common
Rangwala Reshma - Insider Non-Derivative Transactions at KPTI
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Apr 23, 2024 | Sell -- (Common Stock) | 6789 | 1.17 | 342931 |
Mar 2, 2024 | Sell -- (Common) | 5969 | 1.2 | 349720 |
Mar 1, 2024 | Sell -- (Common) | 15667 | 1.17 | 355689 |
Feb 29, 2024 | Acquisition -- (Common Stock) | 198959 | 0 | 371356 |
Jan 25, 2024 | Acquisition -- (Common Stock) | 14167 | 0 | 172397 |
Apr 21, 2023 | Sell -- (Common Stock) | 6655 | 4.05 | 158230 |
Apr 21, 2023 | Sell -- (Common Stock) | 115 | 4.03 | 164885 |
Mar 1, 2023 | Acquisition -- (Common Stock) | 100000 | 0 | 165000 |